Generic placeholder image

当代阿耳茨海默病研究

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Research Article

颅内动脉粥样硬化狭窄与中风后认知障碍有关:较小中风的横断面研究

卷 17, 期 2, 2020

页: [177 - 184] 页: 8

弟呕挨: 10.2174/1567205017666200303141920

价格: $65

摘要

背景:颅内动脉粥样硬化狭窄(ICAS)是认知障碍的重要危险因素。然而,尚不清楚ICAS患者在急性,非致残性缺血性中风(轻度中风)后是否更有可能出现认知障碍。 目的:我们旨在研究ICAS与卒中后认知障碍之间的关系。 方法:在这项横断面研究中,急性,非致残性缺血性中风患者在中风后两周内接受了两次认知测试和ICAS影像学评估。为了确定ICAS与中风后认知障碍之间的关联,我们进行了多因素logistic回归分析,该分析针对多种人口统计学和血管危险因素进行了调整。 结果:在本研究的164例轻度中风患者中,有98例(59.76%)被诊断为中风后认知障碍(蒙特利尔认知评估得分<26)。调整了潜在的混杂因素后,我们发现,与没有ICAS的患者相比,ICAS的患者在发生急性,非致残性缺血性卒中后更容易出现认知功能障碍(几率:2.13; 95%的置信区间:1.07-4.26),在视觉空间和执行功能的测试中表现不佳。 结论:在这项对中风较轻的人群的横断面研究中,我们的发现表明,ICAS与中风后认知障碍之间存在正相关。

关键词: 轻度中风,颅内狭窄,中风后认知障碍,血管性认知障碍,痴呆,横断面研究。

[1]
Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 8(11): 1006-18. (2009).
[http://dx.doi.org/10.1016/S1474-4422(09)70236-4] [PMID: 19782001]
[2]
Sun JH, Tan L, Yu JT. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med 2(8): 80. (2014).
[PMID: 25333055]
[3]
Divya KP, Menon RN, Varma RP, et al. Post-stroke cognitive impairment - A cross-sectional comparison study between mild cognitive impairment of vascular and non-vascular etiology. J Neurol Sci 372: 356-62. (2017).
[http://dx.doi.org/10.1016/j.jns.2016.10.031] [PMID: 27836108]
[4]
Arba F, Quinn TJ, Hankey GJ, et al. Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack. Int J Stroke 13(1): 47-56. (2018).
[http://dx.doi.org/10.1177/1747493016666091] [PMID: 27543501]
[5]
Guo J, Su W, Fang J, et al. Elevated CRP at admission predicts post-stroke cognitive impairment in Han Chinese patients with intracranial arterial stenosis. Neurol Res 40(4): 292-6. (2018).
[http://dx.doi.org/10.1080/01616412.2018.1438224] [PMID: 29451096]
[6]
OBrien RJ. Vascular dementia: atherosclerosis, cognition and Alzheimer’s disease. Curr Alzheimer Res 8(4): 341-4. (2011).
[http://dx.doi.org/10.2174/156720511795745267] [PMID: 21557721]
[7]
Zhu J, Wang Y, Li J, Deng J, Zhou H. Intracranial artery stenosis and progression from mild cognitive impairment to Alzheimer disease. Neurology 82(10): 842-9. (2014).
[http://dx.doi.org/10.1212/WNL.0000000000000185] [PMID: 24489130]
[8]
Wang A, Liu X, Chen G, Hao H, Wang Y, Wang Y. Association between carotid plaque and cognitive impairment in Chinese stroke population: The SOS-Stroke Study. Sci Rep 7(1): 3066. (2017).
[http://dx.doi.org/10.1038/s41598-017-02435-3] [PMID: 28596524]
[9]
Pantoni L, Poggesi A, Basile AM, et al. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc 54(7): 1095-101. (2006).
[http://dx.doi.org/10.1111/j.1532-5415.2006.00798.x] [PMID: 16866681]
[10]
Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 284(22): 2901-6. (2000).
[http://dx.doi.org/10.1001/jama.284.22.2901] [PMID: 11147987]
[11]
Lees R, Corbet S, Johnston C, Moffitt E, Shaw G, Quinn TJ. Test accuracy of short screening tests for diagnosis of delirium or cognitive impairment in an acute stroke unit setting. Stroke 44(11): 3078-83. (2013).
[http://dx.doi.org/10.1161/STROKEAHA.113.001724] [PMID: 23988641]
[12]
Chiti G, Pantoni L. Use of Montreal Cognitive Assessment in patients with stroke. Stroke 45(10): 3135-40. (2014).
[http://dx.doi.org/10.1161/STROKEAHA.114.004590] [PMID: 25116881]
[13]
Kleindorfer D, Panagos P, Pancioli A, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 36(4): 720-3. (2005).
[http://dx.doi.org/10.1161/01.STR.0000158917.59233.b7] [PMID: 15731465]
[14]
Pollock A, St George B, Fenton M, Firkins L. Top ten research priorities relating to life after stroke. Lancet Neurol 11(3): 209. (2012).
[http://dx.doi.org/10.1016/S1474-4422(12)70029-7] [PMID: 22341029]
[15]
Giudetti AM, Romano A, Lavecchia AM, Gaetani S. The role of brain cholesterol and its oxidized products in Alzheimer’s disease. Curr Alzheimer Res 13(2): 198-205. (2016).
[http://dx.doi.org/10.2174/1567205012666150921103426] [PMID: 26391039]
[16]
Zheng L, Duan J, Duan X, et al. Association of apolipoprotein E (ApoE) pPolymorphism with Alzheimer’s disease in chinese population. Curr Alzheimer Res 13(8): 912-7. (2016).
[http://dx.doi.org/10.2174/1567205013666160401115307] [PMID: 27033052]
[17]
Cui X, Chopp M, Zhang Z, et al. ABCA1/ApoE/HDL pathway mediates GW3965-induced neurorestoration after stroke. Stroke 48(2): 459-67. (2017).
[http://dx.doi.org/10.1161/STROKEAHA.116.015592] [PMID: 28028143]
[18]
Albert M, Soldan A, Gottesman R, et al. Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype. Curr Alzheimer Res 11(8): 773-84. (2014).
[http://dx.doi.org/10.2174/156720501108140910121920] [PMID: 25212916]
[19]
Oveisgharan S, Buchman AS, Yu L, et al. APOE ε2ε4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology 90(24): e2127-34. (2018).
[http://dx.doi.org/10.1212/WNL.0000000000005677] [PMID: 29752306]
[20]
Di Battista AM, Heinsinger NM, Rebeck GW. Alzheimer’s disease genetic risk factor APOE-ε4 also affects normal brain function. Curr Alzheimer Res 13(11): 1200-7. (2016).
[http://dx.doi.org/10.2174/1567205013666160401115127] [PMID: 27033053]
[21]
Crystal HA, Schneider JA, Bennett DA, Leurgans S, Levine SR. Associations of cerebrovascular and Alzheimer’s disease pathology with brain atrophy. Curr Alzheimer Res 11(4): 309-16. (2014).
[http://dx.doi.org/10.2174/1567205011666140302194358] [PMID: 24597507]
[22]
Brainin M, Tuomilehto J, Heiss WD, Bornstein NM, Bath PMW, Teuschl Y, et al. Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol 22(2): 229-238, e13-e16. (2015).
[http://dx.doi.org/10.1111/ene.12626] [PMID: 25492161]
[23]
Huang YN, Gao S, Li SW, et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 48(2): 524-5. (1997).
[http://dx.doi.org/10.1212/WNL.48.2.524] [PMID: 9040750]
[24]
Li H, Wong KS. Racial distribution of intracranial and extracranial atherosclerosis. J Clin Neurosci 10(1): 30-4. (2003).
[http://dx.doi.org/10.1016/S0967-5868(02)00264-3] [PMID: 12464517]
[25]
Wong KS, Ng PW, Tang A, Liu R, Yeung V, Tomlinson B. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 68(23): 2035-8. (2007).
[http://dx.doi.org/10.1212/01.wnl.0000264427.09191.89] [PMID: 17548555]
[26]
De Silva DA, Ancalan M, Doshi K, Chang HM, Wong MC, Chen C. Intracranial large artery disease in Alzheimer’s disease and vascular dementia among ethnic Asians. Eur J Neurol 16(5): 643-5. (2009).
[http://dx.doi.org/10.1111/j.1468-1331.2009.02551.x] [PMID: 19222553]
[27]
Kim TW, Song IU, Jeong DS, Lee KS. Clinical effect of cerebrovascular atherosclerosis on cognition in Alzheimer’s disease. Arch Gerontol Geriatr 63: 55-8. (2016).
[http://dx.doi.org/10.1016/j.archger.2015.11.009] [PMID: 26631627]
[28]
Hilal S, Xu X, Ikram MK, Vrooman H, Venketasubramanian N, Chen C. Intracranial stenosis in cognitive impairment and dementia. J Cereb Blood Flow Metab 37(6): 2262-9. (2017).
[http://dx.doi.org/10.1177/0271678X16663752] [PMID: 27488908]
[29]
Man BL, Fu YP, Wong A, et al. Cognitive and functional impairments in ischemic stroke patients with concurrent small vessel and large artery disease. Clin Neurol Neurosurg 113(8): 612-6. (2011).
[http://dx.doi.org/10.1016/j.clineuro.2011.04.001] [PMID: 21530070]
[30]
Suri MFK, Zhou J, Qiao Y, et al. Cognitive impairment and intracranial atherosclerotic stenosis in general population. Neurology 90(14): e1240-7. (2018).
[http://dx.doi.org/10.1212/WNL.0000000000005250] [PMID: 29523643]
[31]
Li P, Quan W, Lu D, et al. Association between metabolic syndrome and cognitive impairment after acute ischemic stroke: a cross-sectional study in a chinese population. PLoS One 11(12)e0167327 (2016).
[http://dx.doi.org/10.1371/journal.pone.0167327] [PMID: 27936074]
[32]
Pantoni L, Poggesi A, Inzitari D. The relation between white-matter lesions and cognition. Curr Opin Neurol 20(4): 390-7. (2007).
[http://dx.doi.org/10.1097/WCO.0b013e328172d661] [PMID: 17620872]
[33]
Gong L, Liu XY, Fang M. Recent progress on small vessel disease with cognitive impairment. Int J Clin Exp Med 8(5): 7701-9. (2015).
[PMID: 26221320]
[34]
Suri MF, Qiao Y, Ma X, et al. Prevalence of intracranial atherosclerotic stenosis using high-resolution magnetic resonance angiography in the general population: the atherosclerosis risk in communities study. Stroke 47(5): 1187-93. (2016).
[http://dx.doi.org/10.1161/STROKEAHA.115.011292] [PMID: 27056984]
[35]
Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369(1): 11-9. (2013).
[http://dx.doi.org/10.1056/NEJMoa1215340] [PMID: 23803136]
[36]
Levine DA, Galecki AT, Langa KM, et al. Trajectory of cognitive decline after incident stroke. JAMA 314(1): 41-51. (2015).
[http://dx.doi.org/10.1001/jama.2015.6968] [PMID: 26151265]
[37]
Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol 9(9): 895-905. (2010).
[http://dx.doi.org/10.1016/S1474-4422(10)70164-2] [PMID: 20723846]
[38]
Boehm-Sturm P, Füchtemeier M, Foddis M, et al. Neuroimaging biomarkers predict brain structural connectivity change in a mouse model of vascular cognitive impairment. Stroke 48(2): 468-75. (2017).
[http://dx.doi.org/10.1161/STROKEAHA.116.014394] [PMID: 28070001]
[39]
Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 34(2): 335-7. (2003).
[http://dx.doi.org/10.1161/01.STR.0000054050.51530.76] [PMID: 12574528]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy